Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subjective Well Being of Schizophrenic Patients in Greece

NCT00857064 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00857064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00857064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subjective Well Being of Schizophrenic Patients in Greece
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 31, 2009
Completion date
October 31, 2009
Enrollment
600 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia